Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Nevirapine

Nevirapine Impurities

Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that is used in the treatment of HIV-1 infection. Its impurity profile includes structurally related analogs, residual solvents, and degradation products. These products can be formed under stress conditions such as hydrolysis, oxidation, and photolysis. Typical degradation pathways of Nevirapine involve oxidative breakdown of the dipyridyl moiety, hydrolytic cleavage of amide bonds, and rearrangement of substituents within the heteroaromatic scaffold. These impurities may affect the potency, stability, and safety of the drug. Thus, all impurities are structurally characterized and qualified according to ICH guidelines for toxicological assessment and analytical validation.

Nevirapine EP Impurities

We provide the pharmacopeial and non-pharmacopeial Nevirapine impurity compounds, which are available in compliance with European Pharmacopoeia (EP) specifications. These standards can be used for the support of analytical method development, impurity profiling, and long-term stability studies. Thus, EP traceable materials are supplied with validated analytical data, including purity, structural confirmation, and spectral characterization.

Nevirapine Related Compounds

Structurally related compounds and synthetic analogs of Nevirapine are included for impurity identification, toxicological qualification, and regulatory submission. These related substances are used in forced degradation studies, genotoxicity assessments, and impurity threshold evaluations. The Nevirapine related compounds are essential for understanding the impurity profile and ensuring compliance with regulatory limits.

Nevirapine Impurity Reference Standards

We provide the Nevirapine impurity reference standards that are available with validated analytical data, including purity, NMR, MS, and full Certificates of Analysis. These standards are used in pharmaceutical research, method validation, and GMP-compliant quality control. We also synthesize the EP/USP traceable impurities, which are available upon request and are routinely re-tested to ensure consistency and reliability.

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 129618-40-2

Mol F.

: C15H14N4O

Mol W.

: 266.8

Cat No.

: SA86600

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 133627-17-5

Mol F.

: C14H14N4O

Mol W.

: 254.3

Cat No.

: SA86601

Please enquire for price & pack size
PLEASE ENQUIRE

CAS No.

: 287980-84-1

Mol F.

: C12H10N4O

Mol W.

: 226.2

Cat No.

: SA86602

Registration

Register to add the product to RFQ list

Already have an account?